Create Account | Sign In: Author or Forum

News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
Category: Family Medicine | Gynecology | Internal Medicine | Nursing | Oncology | Pathology | Pharmacy | Journal

Back to Journal Articles

Folic Acid Supplementation Has No Effect on Cancer Incidence

Last Updated: January 25, 2013.


Over five years of supplementation, no significant effect on overall, site-specific cancer incidence

Share |

Comments: (0)



Folic acid supplementation has no effect on the risk of cancer in the first five years of treatment, according to a meta-analysis published online Jan. 25 in The Lancet.

FRIDAY, Jan. 25 (HealthDay News) -- Folic acid supplementation has no effect on the risk of cancer in the first five years of treatment, according to a meta-analysis published online Jan. 25 in The Lancet.

Noting that some countries have been hesitant to fortify flour with folic acid due to concerns about cancer incidence, Stein Emil Vollset, M.D., from the Norwegian Institute of Public Health in Bergen, and colleagues conducted a meta-analysis of data from 49,621 participants in 13 trials that compared folic acid with placebo and recorded data on cancer incidence. The authors sought to examine any effects of site-specific cancer rates with folic acid supplementation.

The researchers found that, during a weighted average scheduled treatment duration of 5.2 years, participants randomized to receive folic acid versus placebo had a four-fold increase in the plasma concentration of folic acid (57.3 versus 13.5 nmol/L). However, no significant effect was observed on overall cancer incidence, and there was no indication of a greater effect with longer duration of treatment. The results of the individual trials were not marked by significant heterogeneity. Folic acid supplementation also had no significant effect on the incidence of cancer of the large intestine, prostate, breast, lung, or any other specific site.

"The present meta-analysis rules out moderate increases in overall cancer incidence from folic acid supplementation during the trials," the authors write. "Nationwide dietary fortification involves doses of folic acid that are an order of magnitude lower than the doses studied in these trials."

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Health News Copyright © 2013 HealthDay. All rights reserved.

Previous: Tofacitinib Slows Joint Damage in Rheumatoid Arthritis Next: Marked Geographic Variation in Mental Health Medication Use

Reader comments on this article are listed below. Review our comments policy.

Submit your opinion:





Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application


 advertisement.gif (61x7 -- 0 bytes)



Useful Sites
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2015
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.